10-26201286-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_017433.5(MYO3A):āc.4567C>Gā(p.Arg1523Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000437 in 1,578,922 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_017433.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 151744Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000505 AC: 12AN: 237596Hom.: 0 AF XY: 0.0000467 AC XY: 6AN XY: 128522
GnomAD4 exome AF: 0.0000252 AC: 36AN: 1427060Hom.: 1 Cov.: 25 AF XY: 0.0000296 AC XY: 21AN XY: 710604
GnomAD4 genome AF: 0.000217 AC: 33AN: 151862Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74248
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
- -
- -
This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 1523 of the MYO3A protein (p.Arg1523Gly). This variant is present in population databases (rs727504688, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with MYO3A-related conditions. ClinVar contains an entry for this variant (Variation ID: 179176). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
The p.Arg1523Gly variant in MYO3A has been previously identified by our laborato ry in 2 individuals with hearing loss; however, an alternate explanation of the hearing loss was identified in 1 of these individuals. This variant has also be en identified in 0.07% (16/22738) of African chromosomes by the Genome Aggregati on Database (gnomAD, http://gnomad.broadinstitute.org/; dbSNP rs727504688). Alth ough this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. Computational predi ction tools and conservation analysis suggest that the p.Arg1523Gly variant may impact the protein, though this information is not predictive enough to determin e pathogenicity. In summary, the clinical significance of the p.Arg1523Gly varia nt is uncertain. ACMG/AMP Criteria applied: PP3. -
Inborn genetic diseases Uncertain:1
The c.4567C>G (p.R1523G) alteration is located in exon 33 (coding exon 31) of the MYO3A gene. This alteration results from a C to G substitution at nucleotide position 4567, causing the arginine (R) at amino acid position 1523 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Autosomal recessive nonsyndromic hearing loss 30 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at